Company news


Yingsheng Bio won the title of "2019 China Medical Device Technology Innovation Enterprise, Law-abiding and Honest Enterprise"

Inputtime:2020-10-28 13:39:20 Views:

On August 7, 2020, the press conference of the 2019 Most Influential List of China's Pharmaceutical Industry was successfully held in Nanchang. The conference released the list of Chinese medical device technology innovation enterprises and law-abiding and honest enterprises in 2019, and Shandong Yingsheng Biotechnology Co., Ltd. (hereinafter referred to as "Yingsheng Bio") was successfully selected.

The press conference of the most influential list of China's pharmaceutical industry has been held for six consecutive times, becoming the annual brand event of China's pharmaceutical industry. Yingsheng Bio has been awarded the title of "China Medical Device Technology Innovation Enterprise" for two consecutive years, and also won the title of "Law-abiding and Honest Enterprise", which has been widely recognized by industry leaders and experts.
Since its establishment more than ten years ago, Yingsheng Bio has been committed to the research of genomics and metabonomics, and has become the leader of one-stop solution for clinical mass spectrometry in China. Through independent innovation, we have successfully developed domestic leading LC-MS/MS, ICP-MS, intelligent pretreatment platform, full spectrum vitamin 14 detection kit, genetic metabolic disease screening kit, drug concentration detection kit, deafness gene detection kit, folic acid metabolism ability detection kit, ankylosing spondylitis detection kit, full spectrum mineral detection kit, etc., and successfully built domestic leading gene detection platform, mass spectrometry detection platform, quality control platform and clinical mass spectrometry maintenance center. Yingsheng Bio will keep its mission in mind, continue to intensify scientific and technological innovation, comprehensively upgrade its corporate brand, build a landmark enterprise, and contribute its own strength to the development of clinical mass spectrometry detection industry and accurate medical diagnosis industry in China.